Search research articles
Contact Us
Filters
Showing results (161-170 of 261) with videos related to
Page
of 27
Sort By:
Biomedicines
|
December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Anne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
JHEP Reports : Innovation in Hepatology
|
August 11, 2020
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, et al.
Gastroenterology
|
February 14, 2016
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu, Stephen A Harrison, Sven Francque, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
Zobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.
Nature Reviews. Gastroenterology & Hepatology
|
July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosis
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
The Journal of Clinical Investigation
|
January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
Chris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Diabetologia
|
June 30, 2017
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study
Elina Isokuortti, You Zhou, Markku Peltonen, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
Mohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Hepatology (Baltimore, Md.)
|
June 9, 2021
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis
Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 261) with videos related to
Sort By:
Page
of 27
Biomedicines
|
December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Anne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
JHEP Reports : Innovation in Hepatology
|
August 11, 2020
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, et al.
Gastroenterology
|
February 14, 2016
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu, Stephen A Harrison, Sven Francque, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
Zobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.
Nature Reviews. Gastroenterology & Hepatology
|
July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosis
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 5, 2024
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
The Journal of Clinical Investigation
|
January 7, 2015
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
Chris J Weston, Emma L Shepherd, Lee C Claridge, et al.
Diabetologia
|
June 30, 2017
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study
Elina Isokuortti, You Zhou, Markku Peltonen, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
Mohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Hepatology (Baltimore, Md.)
|
June 9, 2021
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis
Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, et al.
Page
of 27